Associate Sponsors

Co-sponsor

Sales decline 7.90% to Rs 1272.69 crore

Net Loss of Ranbaxy Laboratories reported to Rs 368.26 crore in the quarter ended September 2014 as against net loss of Rs 842.23 crore during the previous quarter ended September 2013. Sales declined 7.90% to Rs 1272.69 crore in the quarter ended September 2014 as against Rs 1381.84 crore during the previous quarter ended September 2013. ParticularsQuarter EndedSep. 2014Sep. 2013% Var.Sales1272.691381.84 -8 OPM %-12.23-7.37 -PBDT-272.48-168.60 -62 PBT-332.63-263.01 -26 NP-368.26-842.23 56

Powered by Capital Market - Live News

More From This Section

First Published: Oct 29 2014 | 8:07 AM IST

Next Story